Help us fund research to slow, stop and reverse Parkinson’s
Join us for our next webinar on Wednesday 2nd October 2019 at 17.30pm (GMT) in partnership with the Journal of Parkinson’s Disease and Parkinson’s Movement... Read more
Now in its third year, Dr Tilo Kunath is the winner of this year's Tom Isaacs Award... Read more
The 2019 international Linked Clinical Trials meeting was held at the end of August in Grand Rapids, Michigan - this annual event is an important date in our calendar and heralds the process by which we are bringing much needed novel therapies for the Parkinson's into clinical trial as quickly as possible... Read more
Two genes when mutated, PINK1 and PARKIN, are associated with young onset Parkinson's. Exactly why they increase the risk of developing Parkinson's has long been a mystery, but now Canadian scientists have published research that might be able to explain this increased susceptibility... Read more
Help us fund research to slow, stop and reverse Parkinson’s.
Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.
Although its exact role isn’t yet clear because findings have been conflicting, in this easy-to-read overview the link between the appendix and risk of developing Parkinson's is discussed...
Chinese researchers in collaboration with scientists from the University of Iowa have today published new research suggesting that a drug, called Terazosin - which is used to treat enlarged prostates and high blood pressure - could be a useful drug to re-purpose for Parkinson's. Read more
Recently announced results from a clinical trial provide interesting support for a major theory about Parkinson's, and hope for individuals suffering from one of the common non-motor issues, constipation. Read more
In this study, Prof. Brundin and his team demonstrate the importance of microglia (the immune cells in the brain) to the transfer of the Parkinson's-associated protein alpha synuclein in the brain. They suggested that pharmacological regulation of neuroinflammation could represent a future therapy for Parkinson's... Read more
The Cure Parkinson’s Trust team are excited to be coming together this October to take part in the annual Ricky Road Run and would be delighted if you'd join them to help raise awareness and funds for CPT’s research into a cure for Parkinson’s. Read more
Join us for our autumn research update meeting... Read more
The London 10,000 is a fantastic 10k run organised by the team behind the London Marathon. It starts and finishes in St James’s Park with runners passing many of London’s most famous sights. Read more